204 related articles for article (PubMed ID: 24973797)
1. Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.
Cheah AL; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
BMC Infect Dis; 2014 Jun; 14():353. PubMed ID: 24973797
[TBL] [Abstract][Full Text] [Related]
2. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
Peel T; Cheng AC; Spelman T; Huysmans M; Spelman D
Clin Microbiol Infect; 2012 Apr; 18(4):388-94. PubMed ID: 21848977
[TBL] [Abstract][Full Text] [Related]
3. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
[TBL] [Abstract][Full Text] [Related]
4. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.
Vydra J; Shanley RM; George I; Ustun C; Smith AR; Weisdorf DJ; Young JA
Clin Infect Dis; 2012 Sep; 55(6):764-70. PubMed ID: 22693346
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting.
Xie O; Slavin MA; Teh BW; Bajel A; Douglas AP; Worth LJ
BMC Infect Dis; 2020 Mar; 20(1):228. PubMed ID: 32188401
[TBL] [Abstract][Full Text] [Related]
6. Impact of vanB vancomycin-resistant enterococcal bacteraemia analysed as a time-varying covariate on length of hospital stay.
Cheah AL; Spelman T; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
Epidemiol Infect; 2014 Dec; 142(12):2667-71. PubMed ID: 25372228
[TBL] [Abstract][Full Text] [Related]
7. Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme (AESOP) Annual Report 2017.
Coombs GW; Daley DA; Lee YT; Pang S
Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522664
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations, characteristics, and outcome of infections caused by vancomycin-resistant enterococci at a tertiary care center in Lebanon: A case-case-control study.
Abi Frem J; Ghanem M; Doumat G; Kanafani ZA
J Infect Public Health; 2023 May; 16(5):741-745. PubMed ID: 36958169
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009.
McCracken M; Wong A; Mitchell R; Gravel D; Conly J; Embil J; Johnston L; Matlow A; Ormiston D; Simor AE; Smith S; Du T; Hizon R; Mulvey MR;
J Antimicrob Chemother; 2013 Jul; 68(7):1505-9. PubMed ID: 23524466
[TBL] [Abstract][Full Text] [Related]
10. Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study.
Gouliouris T; Warne B; Cartwright EJP; Bedford L; Weerasuriya CK; Raven KE; Brown NM; Török ME; Limmathurotsakul D; Peacock SJ
J Antimicrob Chemother; 2018 Jun; 73(6):1692-1699. PubMed ID: 29548009
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin-resistant enterococcus bacteraemia in an endemic region: clinical features and genomic analysis: a 12-year cohort.
Abu-Lybdeh O; Murik O; Oster Y; Assous MV; Mann T; Zeevi DA; Benenson S; Wiener-Well Y
J Hosp Infect; 2022 Mar; 121():105-113. PubMed ID: 34896188
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia.
Kohler P; Eshaghi A; Kim HC; Plevneshi A; Green K; Willey BM; McGeer A; Patel SN;
PLoS One; 2018; 13(3):e0193926. PubMed ID: 29566004
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of vancomycin resistant enterococci in a tertiary care hospital in Saudi Arabia.
Somily AM; Al-Mohizea MM; Absar MM; Fatani AJ; Ridha AM; Al-Ahdal MN; Senok AC; Al-Qahtani AA
Microb Pathog; 2016 Aug; 97():79-83. PubMed ID: 27247096
[TBL] [Abstract][Full Text] [Related]
14. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
[TBL] [Abstract][Full Text] [Related]
15. Species, antibiotic susceptibility profiles and van gene frequencies among enterococci isolated from patients at Mulago National Referral Hospital in Kampala, Uganda.
Kateete DP; Edolu M; Kigozi E; Kisukye J; Baluku H; Mwiine FN; Najjuka CF
BMC Infect Dis; 2019 May; 19(1):486. PubMed ID: 31151413
[TBL] [Abstract][Full Text] [Related]
16. Thirty years of VRE in Germany - "expect the unexpected": The view from the National Reference Centre for Staphylococci and Enterococci.
Werner G; Neumann B; Weber RE; Kresken M; Wendt C; Bender JK;
Drug Resist Updat; 2020 Dec; 53():100732. PubMed ID: 33189998
[TBL] [Abstract][Full Text] [Related]
17. Impact of Enterococcal Bacteremia in Liver Transplant Recipients.
Kim YJ; Jun YH; Choi HJ; You YK; Kim DG; Choi JY; Yoon SK; Kim SI
Transplant Proc; 2019 Oct; 51(8):2766-2770. PubMed ID: 31493916
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients.
Papadimitriou-Olivgeris M; Drougka E; Fligou F; Kolonitsiou F; Liakopoulos A; Dodou V; Anastassiou ED; Petinaki E; Marangos M; Filos KS; Spiliopoulou I
Infection; 2014 Dec; 42(6):1013-22. PubMed ID: 25143193
[TBL] [Abstract][Full Text] [Related]
19. vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality.
Suppola JP; Kolho E; Salmenlinna S; Tarkka E; Vuopio-Varkila J; Vaara M
J Clin Microbiol; 1999 Dec; 37(12):3934-9. PubMed ID: 10565910
[TBL] [Abstract][Full Text] [Related]
20. Increasing trend in enterococcal bacteraemia and vancomycin resistance in a tertiary care hospital in Croatia, 2017-2021.
Todorić Z; Majdandžić I; Keretić Kregar T; Herljević Z; Ćorić M; Lešin J; Kuliš T; Mareković I
Infect Dis (Lond); 2023 Jan; 55(1):9-16. PubMed ID: 36240424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
